Posts Tagged: TRIPS agreement
Assessing the Damage from Our COVID Technology Giveaway
The implications of the announcement that the Biden Administration will support efforts to waive intellectual property protection for COVID-19 vaccines and therapies is still sinking in. The …
Waiving IP Rights During Times of COVID: A ‘False Good Idea’
Over the course of four months, close to 850 million doses of COVID-19 vaccines have been administered in over 100 countries. To the extent the unprecedented pace of research, …
Why Innovation Would Survive a COVID-19 TRIPS Waiver
Intellectual property protection has played an important role in this pandemic. As some have pointed out, without legal protection for innovative ideas, there may not have been …
India and South Africa’s COVID Vaccine Proposal to the WTO: Why Patent Waiver Must Be Considered Over Compulsory Licensing
While coronavirus spent the majority of 2020 wreaking havoc on earth, pharmaceutical companies have been busy at work trying to invent a vaccine to combat it. Several companies, …
The New U.S. Essential Patents Statement – Safeguarding the Integrity of the Patent System
In withdrawing the 2013 statement, the new 2019 guidance by the DOJ, NIST and the USPTO states the obvious, i.e. that there is no difference in the law …
INTA Brief to WTO Revives Plain Packaging Debate
Australia’s Tobacco Plain Packaging Act (TPPA) was enacted in 2011 and prohibits all use of trademarks (other than word marks) on tobacco product packaging. The law seemingly …
The Chinese “Super Trademark”: A Creative Strategy for Overseas IP Protection
Enforcement of trademark rights in China is an ongoing issue faced by numerous corporations. Invalidating or canceling a trademark registration in the Chinese market is time-consuming and …
Choosing Between Patents and Trade Secrets, A Discussion Worth Revisiting
Patenting and secrecy are the two major methods of protecting technology that supports competitive advantage. Trade secrets protect a wide range of confidential information, ranging from customer …
Trump Administration to open probe into deceptive intellectual property policy in China
Plans are being made by the Trump administration to open a probe into deceptive Chinese trade practices by invoking Section 301 of the Trade Act of 1974... Where joint …
Big Pharma, Generics and Trade Related Aspects of Intellectual Property Rights (TRIPS)
Generic drug manufacturers can pose major financial threats to those companies that invent and develop the copied drugs both domestically and internationally... Before TRIPS, most of the …
President-Elect Trump Says the TPP is Dead, but What Now for IP?
President-Elect Donald Trump has announced that he will withdraw the United States from the Trans-Pacific Partnership (TPP) agreement on his first day in office. So ends more …
Recent study on lost copyright royalties may reopen WTO case on Section 110 exemptions in U.S.
A recent report from French consulting firm PMP Conseil made waves in the media for indicating that public performance exemptions in U.S. copyright law, such as …
Estimating the Costs for Filing, Registering, and Renewing Single-class Trademarks across the Globe
Estimates for renewing the trademark for one term (including the attorney costs) in the U.S. and the other seven Convention countries vary from $320 in Thailand to $2,120 …
UN Secretary General’s Panel on Access to Medicines Reports: Government Knows Best
Delayed for months beyond its expected issue date the Secretary General's High Level Panel on Access to Medicine's report emerged yesterday. Apparently the panelists scrambled to better …
Brand Owners Watch as Smoke Clears on Plain Packaging Efforts
The major premise of plain packaging is that when stripped of producers’ logos, brand images and promotional matter, tobacco products simply aren’t as attractive to consumers. …
